LONGi publishes its annual report for 2022 and 2023 Q1
24.5.2023 13:06:07 CEST | news aktuell GmbH | Press release
Xi'an, China | Frankfurt, Germany: May 24, 2023 - LONGi Green Energy Technology, a global leading renewable energy company, released its annual report for 2022 and 2023 Q1. According to the financial report, the company achieved a revenue of 128.998 billion yuan in 2022 (USD 19.27 bn), a year-on-year increase of 60.03%. This is the first time that LONGi’s yearly revenue stands above the 100 bn yuan (USD 14.93 bn) level.
For the first quarter of 2023, LONGi’s revenue reached 28.319 billion yuan (USD 4.24 bn), up 52.35% from last year. In the report, LONGi announced that its 2023 revenue is expected to surpass 160 bln yuan (USD 23.95 bn).
The report shows that in 2022 LONGi has produced a total of 85.06GW of monocrystalline silicon wafers, including 42.52GW for external sales and 42.54GW for internal use, steadily ranking 1st in global shipments of monocrystalline silicon wafers for 9 consecutive years.
In Europe, LONGi generated a turnover of 21.34 bn yuan (USD 3.19 bn) in 2022, an increase by 87.68 percent compared to the previous year. Nick Wang, Vice President of LONGi Europe Distributed Generation (DG) said: “Europe is our top priority market globally. The continent is facing unprecedented growth in the solar industry and seeing an increase in demand for high-efficiency and high-quality solar modules as a result. We are preparing for this next stage of solar growth in a sustainable, healthy way, while further enhancing our customers’ focus putting them at the center of our work. As part of this, LONGi will establish a new service and operation center in the EU in 2023 to provide the speed and support our partners need.”
(Currency conversion rates used: December 31, 2022 - USD/CNY 1:6.6946 I
March 31, 2023 - USD/CNY 1:6.6817)
The full press release and further info:
https://www.longi.com/en/distributorbriefing/LONGi-annual-report-2022-and-2023-Q1
https://www.longi.com/en/investor/
Media Contact:
Nadine Bütow
Head of European Communications (DG)
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:52:44 CEST | Press release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Democracy News Alliance: Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:55:20 CEST | Press release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found.
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 13:06:01 CEST | Press release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 10:17:49 CEST | Press release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom